Gabriele K Hopson, MD | |
2100 N Dr Martin Luther King Jr Blvd, Clovis, NM 88101-9412 | |
(505) 769-2141 | |
(505) 769-7337 |
Full Name | Gabriele K Hopson |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology |
Location | 2100 N Dr Martin Luther King Jr Blvd, Clovis, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023186699 | NPI | - | NPPES |
PENDING | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0101X | Pathology - Anatomic Pathology | 79-181 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gabriele K Hopson, MD Po Box 26666, Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-5356 | Gabriele K Hopson, MD 2100 N Dr Martin Luther King Jr Blvd, Clovis, NM 88101-9412 Ph: (505) 769-2141 |
News Archive
Development of a new method to monitor the effectiveness of human immunodeficiency virus (HIV) treatment at home instead of in hospitals is underway by Penn State researchers.
UT Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma.
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the risk of later therapy-related myelodysplastic syndrome and acute myeloid leukemia, which can often occur with a three-drug combination used to treat these patients.
› Verified 3 days ago
Mr. John David Harris, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2100 N Martin Luther King Blvd, Clovis, NM 88101 Phone: 505-769-7257 Fax: 505-769-7243 |